Laura
Torella
Postdoctoral
Publicaciones (6) Publicaciones de Laura Torella
2024
-
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1
EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131
-
Gene editing in liver diseases
FEBS Letters
-
Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice
PLoS Pathogens, Vol. 20, Núm. 5
2022
-
mRNA and gene editing: Late breaking therapies in liver diseases
Hepatology, Vol. 76, Núm. 3, pp. 869-887
2020
-
In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Precise Deletions Using CRISPR-Cas9
Molecular Therapy - Methods and Clinical Development, Vol. 19, pp. 426-437
2018
-
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Nature Communications, Vol. 9, Núm. 1